203780·Stock-Sector-Healthcare
TIGER NASDAQ BIO
Introduction
The TIGER NASDAQ BIO ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the NASDAQ Biotechnology Index(Price Return)
Investment Points
ETF that diversely invests in global biotechnology or pharmaceutical companies listed in the United States
Benchmark Index
NASDAQ Biotechnology
Benchmark Index Description
An index consisting of stocks listed on the NASDAQ Stock Market®, classified under Biotechnology or Pharmaceuticals based on the Industry Classification Benchmark (ICB).
Issuer
Mirae Asset Global Investments Co.,Ltd.
Brand
TIGER
Total Fee
0.3
Listing Date
2014-08-27
International Securities Code
KR7203780002
Market Information
Market Capitalization
51,840,000,000KRW
Transaction Amount
127,455,167KRW
Trading Volume
5,904
Shares Outstanding
2,400,000
NAV
21,132
52-Week High
25,210KRW
52-Week Low
20,000KRW